References
- Robinson D. S., Harris P. M. The production of lipolytic activity in the circulation of the hind limb in response to heparin. Quart. J. Exp. Physiol. 1959; 44: 80–90
- Robinson D. S., French J. E. Heparin, the clearing factor lipase, and fat transport. Pharmacol. Rev. 1960; 12: 241–263
- Bernfeld P., Kelly T. F. Inhibitory and activating effects of polyanions on lipoprotein lipase. J. Biol. Chem. 1963; 238: 1236–1241
- D'Agostino L., Daniele B., Pignata S., D'Argenio G., Mazzacca G. Modification in erythrocyte diamine oxidase distribution induced by heparin in the rat. Biochem. Pharmacol. 1989; 38: 47–49
- Hansson R., Thysell H. The effect of heparin and some related agents on diamine oxidase in rabbit blood plasma. Acta Physiol. Scand. 1970; 78: 537–546
- Frei B., Stocker R., Ames B. N. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc. Natl. Acad. Sci. USA. 1988; 85: 9748–9752
- Marklund S. L. Human copper-containing superoxide dismutase of high molecular weight. Proc. Natl. Acad. Sci. USA. 1982; 79: 7634–7638
- Karlsson K., Marklund L. Extracellular superoxide dismutase in the vascular system of mammals. Biochem. J. 1988; 255: 223–22
- Karlsson K., Lindahl U., Marklund S. L. Binding of human extracellular SOD C to sulphated glycosaminoglycans. Biochem. J. 1988; 256: 29–33
- Oyanagui Y., Sato S., Okajima T. Suppressions of ischemic paw oedema in mice, rats and guinea pigs by superoxide dismulases from different sources. Free Rad. Res. Comms. 1988; 4: 385–396
- Hugues J., LeComte J. Action inhibitrice de I'heparine sur le phenomene d'Arthus. Int. Arch. Allergy. 1954; 5: 367–373
- Johnasson S.-A. Inhibition of thrombocytopenia and 5-hydroxy-tryptamine release in anaphylactic shock by heparin. Acta Physiol. Scand. 1960; 50: 95–104
- Engelberg H. Heparin therapy of severe cornary atherosclerosis with observation of its effect on angina pectoris. Am. J. Med. Sci. 1952; 224: 488–495
- Lider O., Babarav E., Mekori Y. A., Miller T., Naparstek Y., Vlodavsky I., Cohen I. R. Suppression of experimental autoimmune diseases and prolongation of allograft survival by treatment of animals with low doses of heparins. J. Clin. Invest. 1989; 83: 752–756
- Okada T., Bark D. H., Mayberg M. R. Local anticoagulation without systemic effect using a polymer heparin delivery system. Stroke 1988; 19: 1470–1476
- Folkman J., Langer R., Lindhardt R. J., Haudenschild C., Taylor S. Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone. Science 1983; 221: 719–725
- Folkman J., Weisz P. B., Joullie M. M., Li W. W., Ewing W. R. Control of angiogenesis with synthetic heparin. Science 1989; 243: 1490–1493
- Oyanagui Y. Reevaluation of assay methods and establishment of kit for superoxide dismutase. Analytical Biochem. 1984; 142: 290–296
- McCord J. M., Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein. J. Biol. Chem. 1969; 244: 6049–6055
- Marklund S. L. Spectrophotometric study of spontaneous disproportionation of superoxide anion radical and sensitive direct assay for superoxide dismutase. J. Biol. Chem. 1976; 251: 7504–7507
- Karlson K., Marklund S. L. Plasma clearance of human extracellular-SOD C in rabbits. J. Clin. Invest. 1988; 92: 762–766
- Blech D. M., Borders D. M., Jr. Hydroxide anion, HO2−, is an affinity reagent for the inactivation of yeast Cu,Zn-superoxide dismutase: Modification of one histidine per subunit. Arch. Biochem. Biophys. 1983; 224: 579–586
- Bayer W. F., Jr., Fridovich I., Mullenbach G. T., Hallewell R. Examination of the role of arginine-143 in the human copper and zinc superoxide dismutase by specific mutagenesis. J. Biol. Chem. 1987; 262: 11182–11187